| # | Drug | Count |
|---|---|---|
| 0 | METHYLDOPA | 11 |
| 1 | AMLODIPINE | 7 |
| 2 | BISOPROLOL FUMARATE | 7 |
| 3 | LEVONORGESTREL | 6 |
| 4 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 5 |
| 5 | CANDESARTAN | 5 |
| 6 | PRAMIPEXOLE | 5 |
| 7 | ZIDOVUDINE | 5 |
| 8 | METOPROLOL TARTRATE | 4 |
| 9 | NIFEDIPINE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FENOPROFEN CALCIUM | 1 | 0.0204 |
| 1 | METYRAPONE | 3 | 0.0030 |
| 2 | L-TRYPTOPHAN | 1 | 0.0023 |
| 3 | METHYLDOPA | 11 | 0.0022 |
| 4 | ULIPRISTAL ACETATE | 1 | 0.0020 |
| 5 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 6 | ALMOTRIPTAN | 1 | 0.0009 |
| 7 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 5 | 0.0008 |
| 8 | ZIDOVUDINE | 5 | 0.0005 |
| 9 | PRAMIPEXOLE | 5 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 3 | 0.0030 |
| 1 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 2 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 4 | Progesterone [EPC] | 2 | 0.0001 |
| 5 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |
| 7 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 11 | 0.0000 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |